Literature DB >> 22156874

Epigenetic regulation and colorectal cancer.

Nagahide Matsubara1.   

Abstract

Epigenetic silencing of genes is now recognized to be an important mechanism for inactivation of tumor suppressor genes in carcinogenesis. Because the role of genetic alterations in colorectal carcinogenesis has been well studied, colorectal cancer also offers an excellent model for elucidation of epigenetic mechanisms involved in carcinogenesis. DNA methylation and histone modification are involved in a complex network to maintain gene silencing and cause carcinogenesis. DNA methylation of cancer-related gene promoters generally begins early in the process of tumorigenesis, affecting various types of colorectal cancer to differing degrees. These advances in the understanding of the biology of tumorigenesis can be expected to provide distinct biomarkers that will aid future diagnosis, risk assessment, and treatment methods for patients with colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22156874     DOI: 10.1097/DCR.0b013e318233a1ef

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  14 in total

1.  Significant association of PRMT6 hypomethylation with colorectal cancer.

Authors:  Ranran Pan; Hang Yu; Jie Dai; Cong Zhou; Xiuru Ying; Jie Zhong; Jun Zhao; Yihan Zhang; Boyi Wu; Yiyi Mao; Dongping Wu; Jieer Ying; Shiwei Duan
Journal:  J Clin Lab Anal       Date:  2018-06-21       Impact factor: 2.352

2.  Sevoflurane Suppresses the Proliferation, Migration and Invasion of Colorectal Cancer Through Regulating Circ_0000423/miR-525-5p/SGPP1 Network.

Authors:  Xiaofang Kang; Xiaocong Li; Yanli Li
Journal:  Cell Mol Bioeng       Date:  2022-01-22       Impact factor: 2.321

3.  Human NINEIN polymorphism at codon 1111 is associated with the risk of colorectal cancer.

Authors:  Yukiko Yasuda; Akiko Sakai; Sachio Ito; Kaori Sasai; Akisada Ishizaki; Yoshiya Okano; Seito Kawahara; Yoshimi Jitsumori; Hiromasa Yamamoto; Nagahide Matsubara; Kenji Shimizu; Hiroshi Katayama
Journal:  Biomed Rep       Date:  2020-08-27

Review 4.  Eradicating Cancer Stem Cells: Concepts, Issues, and Challenges.

Authors:  Gurpreet Kaur; Praveen Sharma; Nilambra Dogra; Sandeep Singh
Journal:  Curr Treat Options Oncol       Date:  2018-03-20

5.  Association of visceral obesity and early colorectal neoplasia.

Authors:  Eun Kyung Choe; Donghee Kim; Hwa Jung Kim; Kyu Joo Park
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

Review 6.  Alternatives for the intensive follow-up after curative resection of colorectal cancer. Potential novel biomarkers for the recommendations.

Authors:  Enikő Orosz; István Ember; Katalin Gombos; László Tóth; Ádám Tarpay; Ákos Pap; Szabolcs Ottó
Journal:  Pathol Oncol Res       Date:  2013-07-19       Impact factor: 3.201

7.  Hypermethylation of Corticotropin Releasing Hormone Receptor-2 Gene in Ulcerative Colitis Associated Colorectal Cancer.

Authors:  Masayoshi Kobayashi; Nagahide Matsubara; Yutaka Nakachi; Yasushi Okazaki; Motoi Uchino; Hiroki Ikeuchi; Jihyng Song; Kei Kimura; Michiko Yasuhara; Akihito Babaya; Tomoki Yamano; Masataka Ikeda; Hiroki Nishikawa; Ikuo Matsuda; Seiichi Hirota; Naohiro Tomita
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

8.  Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer.

Authors:  Seiji Ohigashi; Kazuki Sudo; Daiki Kobayashi; Osamu Takahashi; Takuya Takahashi; Takashi Asahara; Koji Nomoto; Hisashi Onodera
Journal:  Dig Dis Sci       Date:  2013-01-11       Impact factor: 3.199

9.  Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population.

Authors:  Rupal Sinha; Showket Hussain; Ravi Mehrotra; R Suresh Kumar; Kapil Kumar; Pankaj Pande; Dinesh Chandra Doval; Seemi Farhat Basir; Mausumi Bharadwaj
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

10.  TRIM24 overexpression is common in locally advanced head and neck squamous cell carcinoma and correlates with aggressive malignant phenotypes.

Authors:  Zhibin Cui; Wei Cao; Jiang Li; Xiaomeng Song; Li Mao; Wantao Chen
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.